How much funding has Alpine Immune raised?

Alpine Immune has raised $108.0M in total funding, most recently a Series B round.

Who are Alpine Immune's investors?

Alpine Immune's investors include Omega Funds, Vertex Pharmaceuticals, OrbiMed, Frazier Healthcare.

When was Alpine Immune founded?

Alpine Immune was founded in 2014.

Where is Alpine Immune headquartered?

Alpine Immune is headquartered in Seattle, Washington, United States.

What industry is Alpine Immune in?

Alpine Immune operates in Biotech, Healthcare.

How many employees does Alpine Immune have?

Alpine Immune has 51-200 employees.

Alpine Immune

Acquired

Seattle, United States · Founded 2014 · $108.0M raised

Biotech

Healthcare

Headquarters: Seattle, Washington
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: alpineimmunesciences.com
Total Funding: $108.0M
Last Round: $60.0M Series BJan 2017
Rounds: 3

About

Clinical-stage biotechnology company developing protein-based immunotherapies for cancer and autoimmune diseases; acquired by Vertex Pharmaceuticals.

Summary

Alpine Immune is a Biotech company based in Seattle, United States, founded in 2014. It has raised $108.0M in total across 3 rounds, most recently a $60.0M Series B round in Jan 2017. Investors include Omega Funds, Vertex Pharmaceuticals and OrbiMed.